1. 247 patients with malaria were treated with Camoquin. Therewere 156 patients in the vivax infection group, 86 patientsin the falciparum infection group, and 5 patients in the malariaeinfection group.
2. There were 19 readmissions to the hospitalin the vivax group,of these 19 patients four patients had twoor more readmissions.There were no readmissions in the falciparumor malariae group.
3. Clinical symptoms were controlled within24 to 48 hours.
4. There were no toxic reactions to the drug.
1 Chief Medical Officer (IIAA) Belem, Para, Brazil.